Literature DB >> 30645778

Osteogenesis Imperfecta: A Need to Understand Divergent Treatment Outcomes in a Disorder Rich in Heterogeneity.

Kenneth M Kozloff.   

Abstract

Entities:  

Year:  2019        PMID: 30645778     DOI: 10.1002/jbmr.3647

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  5 in total

1.  Finite element analysis of bone strength in osteogenesis imperfecta.

Authors:  Peter Varga; Bettina M Willie; Chris Stephan; Kenneth M Kozloff; Philippe K Zysset
Journal:  Bone       Date:  2020-01-22       Impact factor: 4.398

2.  Sclerostin Antibody-Induced Changes in Bone Mass Are Site Specific in Developing Crania.

Authors:  Amanda L Scheiber; David K Barton; Basma M Khoury; Joan C Marini; Donald L Swiderski; Michelle S Caird; Kenneth M Kozloff
Journal:  J Bone Miner Res       Date:  2019-11-07       Impact factor: 6.741

3.  A xenograft model to evaluate the bone forming effects of sclerostin antibody in human bone derived from pediatric osteogenesis imperfecta patients.

Authors:  Rachel K Surowiec; Lauren F Battle; Ferrous S Ward; Stephen H Schlecht; Basma M Khoury; Christopher Robbins; Edward M Wojtys; Michelle S Caird; Kenneth M Kozloff
Journal:  Bone       Date:  2019-10-31       Impact factor: 4.398

Review 4.  Deciphering Myostatin's Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases.

Authors:  Catherine L Omosule; Charlotte L Phillips
Journal:  Front Genet       Date:  2021-03-29       Impact factor: 4.599

5.  Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.

Authors:  Catherine L Omosule; Victoria L Gremminger; Ashley M Aguillard; Youngjae Jeong; Emily N Harrelson; Lawrence Miloscio; Jason Mastaitis; Ashique Rafique; Sandra Kleiner; Ferris M Pfeiffer; Anqing Zhang; Laura C Schulz; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2020-12-18       Impact factor: 6.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.